Adaptive Responses to PARP Inhibition Predict Response to Olaparib and Durvalumab: Multi-omic Analysis of Serial Biopsies in the AMTEC Trial

Zahi I. Mitri; Allison L. Creason; Jayne M. Stommel; Daniel Bottomly; Tugba Y. Ozmen; Matthew J. Rames; Furkan Ozmen; Boyoung Jeong; Natalia Lukashchuk; Jack Ashton; Jeong Youn Lim; Shamilene Sivagnanam; Konjit Betra; Jinho Lee; Marilyne Labrie; SMMART Clinical Trials Program; Lisa M. Coussens; Christopher L. Corless; Shannon K. McWeeney; Gordon B. Mills

doi:10.1101/2024.08.29.24312245

Adaptive Responses to PARP Inhibition Predict Response to Olaparib and Durvalumab: Multi-omic Analysis of Serial Biopsies in the AMTEC Trial

View ORCID ProfileZahi I. Mitri, View ORCID ProfileAllison L. Creason, View ORCID ProfileJayne M. Stommel, View ORCID ProfileDaniel Bottomly, View ORCID ProfileTugba Y. Ozmen, View ORCID ProfileMatthew J. Rames, View ORCID ProfileFurkan Ozmen, View ORCID ProfileBoyoung Jeong, Natalia Lukashchuk, Jack Ashton, View ORCID ProfileJeong Youn Lim, View ORCID ProfileShamilene Sivagnanam, Konjit Betra, View ORCID ProfileJinho Lee, View ORCID ProfileMarilyne Labrie, SMMART Clinical Trials Program, View ORCID ProfileLisa M. Coussens, View ORCID ProfileChristopher L. Corless, View ORCID ProfileShannon K. McWeeney, View ORCID ProfileGordon B. Mills

doi: https://doi.org/10.1101/2024.08.29.24312245

Zahi I. Mitri

1British Columbia Cancer Agency, Vancouver, BC, Canada

2Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Zahi I. Mitri

Allison L. Creason

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

4Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Allison L. Creason

Jayne M. Stommel

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jayne M. Stommel

Daniel Bottomly

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Daniel Bottomly

Tugba Y. Ozmen

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Tugba Y. Ozmen

Matthew J. Rames

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Matthew J. Rames

Furkan Ozmen

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Furkan Ozmen

Boyoung Jeong

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Boyoung Jeong

Natalia Lukashchuk

7Translational Medicine, Oncology Research and Development (R&D), AstraZeneca, Cambridge, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jack Ashton

7Translational Medicine, Oncology Research and Development (R&D), AstraZeneca, Cambridge, United Kingdom

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeong Youn Lim

5Biostatistics Shared Resource, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jeong Youn Lim

Shamilene Sivagnanam

6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Shamilene Sivagnanam

Konjit Betra

6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jinho Lee

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

8Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jinho Lee

Marilyne Labrie

9Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada

10Centre de Recherche du Centre Hospitalier de l’Université de Sherbrooke (CRCHUS), Sherbrooke, Canada

11Institut de Recherche sur le Cancer de l’Université de Sherbrooke (IRCUS), Sherbrooke, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Marilyne Labrie

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

Lisa M. Coussens

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Lisa M. Coussens

Christopher L. Corless

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

8Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Christopher L. Corless

Shannon K. McWeeney

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

12Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Shannon K. McWeeney

Gordon B. Mills

3Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

6Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Gordon B. Mills
For correspondence: millsg@ohsu.edu

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Article Information

doi

https://doi.org/10.1101/2024.08.29.24312245

History

August 30, 2024.

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

View the discussion thread.

PreviousNext

Posted August 30, 2024.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Adaptive Responses to PARP Inhibition Predict Response to Olaparib and Durvalumab: Multi-omic Analysis of Serial Biopsies in the AMTEC Trial

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Adaptive Responses to PARP Inhibition Predict Response to Olaparib and Durvalumab: Multi-omic Analysis of Serial Biopsies in the AMTEC Trial

Zahi I. Mitri, Allison L. Creason, Jayne M. Stommel, Daniel Bottomly, Tugba Y. Ozmen, Matthew J. Rames, Furkan Ozmen, Boyoung Jeong, Natalia Lukashchuk, Jack Ashton, Jeong Youn Lim, Shamilene Sivagnanam, Konjit Betra, Jinho Lee, Marilyne Labrie, SMMART Clinical Trials Program, Lisa M. Coussens, Christopher L. Corless, Shannon K. McWeeney, Gordon B. Mills

medRxiv 2024.08.29.24312245; doi: https://doi.org/10.1101/2024.08.29.24312245

Share This Article: